Announcements Trials

Browse Landscape

Phase

Phase NA 4 Phase 4 2 Phase EARLY_PHASE1 1 Phase 1 1

Status

Recruiting 3 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 25 Breast Neoplasms 21 Colorectal Neoplasms 17 Neoplasms 16 Prostatic Neoplasms 15 Lymphoma, B-Cell 15 Stomach Neoplasms 13 Carcinoma, Hepatocellular 12 Recurrence 11 Pancreatic Neoplasms 11 Lung Neoplasms 11 Leukemia, Myeloid, Acute 11 Carcinoma, Non-Small-Cell Lung 11 Burkitt Lymphoma 11 Solid Tumor 10 Uterine Cervical Neoplasms 9 Lymphoma, Non-Hodgkin 9 Glioblastoma 9 Leukemia 8 Ovarian Neoplasms 7 Glioma 7 Sarcoma 6 Polycystic Ovary Syndrome 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma 5 Hematologic Neoplasms 5 Head and Neck Neoplasms 5 Neuroendocrine Tumors 4 Lymphoma, T-Cell, Peripheral 4

Interventions

Spironolactone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Unknown × Hyperandrogenism × Clear all

NCT04075149 2023-10-27

CBS009

University of Virginia

Phase EARLY_PHASE1 Unknown

Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡